Delay of postnatal maturation sensitizes the mouse prostate to testosterone-induced pronounced hyperplasia: Protective role of estrogen receptor-β

American Journal of Pathology

Volumn 171, Issue 3, 2007, Pages 1013-1022

  Savolainen, Saija ^a   Pakarainen, Tomi ^a   Huhtaniemi, Ilpo ^a,c   Poutanen, Matti ^a   Mäkelä, Sari ^a,b  

^a Institute of Biomedicine   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5ALPHA PREGNANE 3,20 DIONE; AROMATASE INHIBITOR; ESTRADIOL; ESTROGEN RECEPTOR BETA; LUTEINIZING HORMONE RECEPTOR; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESTROGEN ACTIVITY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATITIS; TESTOSTERONE BLOOD LEVEL;

EID: 34548825107     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.060979     Document Type: Article

References (48)

1. Pylkkänen L, Santti R, Newbold R, McLachlan J: Regional differences in the prostate of the neonatally estrogenized mouse. Prostate 1991, 18:117-129
2. Prins GS, Birch L, Couse JF, Choi I, Katzenellenbogen B, Korach KS: Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with αERKO and βERKO mice. Cancer Res 2001, 61:6089-6097
3. Risbridger GP, Bianco JJ, Ellem SJ, McPherson SJ: Oestrogens and prostate cancer. Endocr Relat Cancer 2003, 10:187-191
4. Noble RL: Prostate carcinoma of the Nb rat in relation to hormones. Int Rev Exp Pathol 1982, 23:113-159
5. Drago JR: The induction of NB rat prostatic carcinomas. Anticancer Res 1984, 4:255-256
6. Leav I, Merk FB, Kwan PW, Ho SM: Androgen-supported estrogen-enhanced epithelial proliferation in the prostates of intact Noble rats. Prostate 1989, 15:23-40
7. Bosland MC, Prinsen MK, Rivenson A, Silverman J, Fiala E, Williams GM, Kroes R, Weisburger JH: Induction of proliferative lesions of ventral prostate, seminal vesicle, and other accessory sex glands in rats by N-methyl-N- nitrosourea: effect of castration, pretreatment with cyproterone acetate and testosterone propionate and rat strain. Prostate 1992, 20:339-353
8. Hoover DM, Best KL, McKenney BK, Tamura RN, Neubauer BL: Experimental induction of neoplasia in the accessory sex organs of male Lobund-Wistar rats. Cancer Res 1990, 50:142-146
9. Weihua Z, Mäkelä S, Andersson LC, Salmi S, Saji S, Webster JI, Jensen EV, Nilsson S, Warner M, Gustafsson JA: A role for estrogen receptor β in the regulation of growth of the ventral prostate. Proc Natl Acad Sci USA 2001, 98:6330-6335
10. McPherson SJ, Wang H, Jones ME, Pedersen J, Iismaa TP, Wreford N, Simpson ER, Risbridger GP: Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland. Endocrinology 2001, 142:2458-2467
11. Stanbrough M, Leav I, Kwan PW, Bubley GJ, Balk SP: Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium. Proc Natl Acad Sci USA 2001, 98:10823-10828
12. Lehtimäki J, Mäkelä S, Viljamaa J, Yagi A, Paranko J, Santti R: Neonatal estrogenization of the male mouse results in urethral dysfunction. J Urol 1996, 156:2098-2103
13. Schulze H, Barrack ER: Immunocytochemical localization of estrogen receptors in the normal male and female canine urinary tract and prostate. Endocrinology 1987, 121:1773-1783
14. Bødker A, Balslev E, Iversen HG, Meyhoff HH, Andersson KE: The expression of receptors for estrogen and epithelial growth factor in the male rabbit prostate and prostatic urethra following castration. Scand J Urol Nephrol 1997, 31:15-18
15. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JÅ: Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996, 93:5925-5930
16. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjöld M, Gustafsson JA: Human estrogen receptor B-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 1997, 82:4258-4265
17. Imamov O, Morani A, Shim GJ, Omoto Y, Thulin-Andersson C, Warner M, Gustafsson JA: Estrogen receptor β regulates epithelial cellular differentiation in the mouse ventral prostate. Proc Natl Acad Sci USA 2004, 101:9375-9380
18. Risbridger GP, Wang H, Frydenberg M, Cunha GR: The metaplastic effects of estrogen on mouse prostate epithelium: proliferation of cells with basal cell phenotype. Endocrinology 2001, 142:2443-2450
19. Zhang FP, Poutanen M, Wilbertz J, Huhtaniemi I: Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol Endocrinol 2001, 15:172-183
20. Pakarainen T, Zhang F-P, Mäkelä S, Poutanen M, Huhtaniemi I: Testosterone replacement therapy induces spermatogenesis and partially restores fertility in luteinizing hormone receptor knockout mice. Endocrinology 2005, 146:596-606
21. Ahokoski O, Irjala K, Huupponen R, Halonen K, Salminen E, Scheinin H: Hormonal effects of MPV-2213ad, a new selective aromatase inhibitor, in healthy male subjects. A phase I study. Br J Clin Pharmacol 1998, 45:141-146
22. Li X, Nokkala E, Yan W, Streng T, Saarinen N, Wärri A, Huhtaniemi I, Santti R, Mäkelä S, Poutanen M: Altered structure and function of reproductive organs in transgenic male mice overexpressing human aromatase. Endocrinology 2001, 142:2435-2442
23. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA: Estrogen receptor-β potency-selective ligands: structure-activity relationships studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 2001, 44:4230-4251
24. Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA, Katzenellenbogen BS: Activities of estrogen receptor α- and β-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol 2003, 206:13-22
25. Helguero LA, Faulds MH, Gustafsson JA, Haldosen LA: Estrogen receptors alfa (ERα) and beta (ERβ) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene 2005, 24:6605-6616
26. Wakeling AE, Dukes M, Bowler J: A potent specific pure antiestrogen with clinical potential. Cancer Res 1991, 51:3867-3873
27. Howell A, Osborne CK, Morris C, Wakeling AE: ICI 182,780 (Faslodex): development of a novel, "pure" antiestrogen. Cancer 2000, 89:817-825
28. Huhtaniemi I, Nikula H, Rannikko S: Treatment of prostatic cancer with a gonadotropin-releasing hormone agonist analog: acute and long term effects on endocrine functions of testis tissue. J Clin Endocrinol Metab 1985, 61:698-704
29. Bergendahl M, Perheentupa A, Huhtaniemi I: Effect of short-term starvation on reproductive hormone gene expression, secretion and receptor levels in male rats. J Endocrinol 1989, 121:409-417
30. Shappell SB, Thomas GV, Roberts RL, Herbert R, Ittmann MM, Rubin MA, Humphrey PA, Sundberg JP, Rozengurt N, Barrios R, Ward JM, Cardiff RD: Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res 2004, 64:2270-2305
31. Isaacs JT: Role of androgens in prostatic cancer. Vitam Horm 1994, 49:433-502
32. Pollard M, Luckert PH, Schmidt MA: Induction of prostate adenocarcinomas in Lobund Wistar rats by testosterone. Prostate 1982, 3:563-568
33. Pour PM, Stepan K: Induction of prostatic carcinomas and lower urinary tract neoplasms by combined treatment of intact and castrated rats with testosterone propionate and N-nitrosobis(2-oxopropyl)amine. Cancer Res 1987, 47:5699-5706
34. Grino PB, Griffin JE, Wilson JD: Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone. Endocrinology 1990, 126:1165-1172
35. Weihua Z, Lathe R, Warner M, Gustafsson JÅ: An endocrine pathway in the prostate, ERβ AR, 5α-androstane-3β, 17 β-diol, and CYP7B1, regulates prostate growth. Proc Natl Acad Sci USA 2002, 99:13589-13594
36. Chang EC, Frasor J, Komm B, Katzenellenbogen BS: Impact of estrogen receptor beta on gene networks regulated by estrogen receptor α in breast cancer cells. Endocrinology 2006, 147:4831-4842
37. Risbridger G, Wang H, Young P, Kurita T, Wang YZ, Lubahn D, Gustafsson JA, Cunha G: Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium. Dev Biol 2001, 229:432-442
38. Corbier P, Martikainen P, Pestis J, Härkönen P: Experimental research on the morphofunctional differentiation of the rat ventral prostate: roles of the gonads at birth. Arch Physiol Biochem 1995, 103:699-714
39. Prins GS, Birch L: Neonatal estrogen exposure up-regulates estrogen receptor expression in the developing and adult rat prostate lobes. Endocrinology 1997, 138:1801-1809
40. Wennbo H, Kindblom J, Isaksson OG, Tornell J: Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland. Endocrinology 1997, 138:4410-4415
41. Lane KE, Leav I, Ziar J, Bridges RS, Rand WM, Ho SM: Suppression of testosterone and estradiol-17β-induced dysplasia in the dorsolateral prostate of Noble rats by bromocriptine. Carcinogenesis 1997, 18:1505-1510
42. Brick JE, Wilson DA, Walker SE: Hormonal modulation of response to thymus-independent and thymus-dependent antigens in autoimmune NZB/NZW mice. J Immunol 1985, 134:3693-3698
43. Roubinian J, Talal N, Greenspan JS, Goodman JR, Siiteri PK: Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB7NZW F1 mice. J Exp Med 1978, 147:1568-1583
44. Rajfer J, Coffey DS: Sex steroid imprinting of the immature prostate. Long-term effects. Invest Urol 1978, 16:186-190
45. Shim GJ, Wang L, Andersson S, Nagy N, Kis LL, Zhang Q, Makela S, Warner M, Gustafsson JA: Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proc Natl Acad Sci USA 2003, 100:6694-6699
46. Harris H, Albert L, Leathurby Y, Malamas M, Mewshaw R, Miller C, Kharode Y, Marzolf J, Hkomm B, Winneker R, Frail D, Henderson R, Zhu Y, Keith J: Evaluation of an estrogen receptor β agonist in animal models of human disease. Endocrinology 2003, 144:4241-4249
47. Shim GJ, Gherman D, Kim HJ, Omoto Y, Iwase H, Bouton D, Kis LL, Andersson CT, Warner M, Gustafsson JA: Differential expression of oestrogen receptors in human secondary lymphoid tissues. J Pathol 2006, 208:408-414
48. Törn S, Nokelainen P, Kurkela R, Pulkka A, Menjivar M, Ghosh S, Coca-Prados M, Peltoketo H, Isomaa V, Vihko P: Production, purification, and functional analysis of recombinant human and mouse 17β-hydroxysteroid dehydrogenase type 7. Biochem Biophys Res Commun 2003, 305:37-45